| P6099 | clinical trial phase | phase I clinical trial | Q5452194 |
| | phase II clinical trial | Q42824440 |
| P17 | country | United States of America | Q30 |
| P4135 | maximum age | 18 | |
| P2899 | minimum age | 2 | |
| P1132 | number of participants | 63 | |
| P4844 | research intervention | zolpidem | Q218842 |
| P6153 | research site | Case Western Reserve University | Q1047060 |
| P8005 | research subject recruitment status | completed | Q76651189 |
| P859 | sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development | Q5409765 |
| P580 | start time | 2002-10-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | Single Dose Pharmacokinetic and Pharmacodynamic Evaluation of Three Different Zolpidem Doses in Children Ages 2 to 18 Years of Age | |